166 related articles for article (PubMed ID: 37461382)
1. Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single-centre audit of cellulitis outcomes.
Bowhay TR; Tsang T; Wei JCZ; Edwik W; Fridman A; Hubber J; Jo JY; Mckay N; O'Brien C; Osmond-Wallam J; Smythe J; Crump JA; Arnold B
Intern Med J; 2024 Feb; 54(2):320-327. PubMed ID: 37461382
[TBL] [Abstract][Full Text] [Related]
2. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
Chan M; Ooi CK; Wong J; Zhong L; Lye D
BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
Bader MS; Twells L; Hawboldt J
South Med J; 2011 Dec; 104(12):789-93. PubMed ID: 22089355
[TBL] [Abstract][Full Text] [Related]
4. Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT).
Palit J; Cole J; Durojaiye OC
Diagn Microbiol Infect Dis; 2021 May; 100(1):115305. PubMed ID: 33454560
[TBL] [Abstract][Full Text] [Related]
5. Management of cellulitis in a pediatric emergency department.
Khangura S; Wallace J; Kissoon N; Kodeeswaran T
Pediatr Emerg Care; 2007 Nov; 23(11):805-11. PubMed ID: 18007211
[TBL] [Abstract][Full Text] [Related]
6. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis.
Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K
CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027
[TBL] [Abstract][Full Text] [Related]
7. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
[TBL] [Abstract][Full Text] [Related]
8. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
Dalen D; Fry A; Campbell SG; Eppler J; Zed PJ
Emerg Med J; 2018 Aug; 35(8):492-498. PubMed ID: 29914924
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections.
Brown G; Chamberlain R; Goulding J; Clarke A
J Emerg Med; 1996; 14(5):547-51. PubMed ID: 8933313
[TBL] [Abstract][Full Text] [Related]
10. Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial.
Quirke M; Wakai A; Gilligan P; O'Sullivan R
Trials; 2013 Jun; 14():164. PubMed ID: 23732051
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
[TBL] [Abstract][Full Text] [Related]
12. The impact of an outpatient parenteral antibiotic therapy (OPAT) clinic for adults with cellulitis: an interrupted time series study.
Yadav K; Mattice AMS; Yip R; Rosenberg H; Taljaard M; Nemnom MJ; Ohle R; Yan J; Suh KN; Stiell IG; Eagles D
Intern Emerg Med; 2021 Oct; 16(7):1935-1944. PubMed ID: 33515424
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.
Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA
Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250
[TBL] [Abstract][Full Text] [Related]
14. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
Sumpter C; Russell CD; Mackintosh C
Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
[TBL] [Abstract][Full Text] [Related]
15. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
16. How is income generated by outpatient parenteral antibiotic treatment (OPAT) in the UK? Analysis of payment tariffs for cellulitis.
Jones GR; Cumming DV; Honeywell G; Ball R; Sanderson F; Seaton RA; Healy B; Hedderwick S; Gilchrist M;
J Antimicrob Chemother; 2015 Apr; 70(4):1236-40. PubMed ID: 25558074
[TBL] [Abstract][Full Text] [Related]
17. The Penicillin for the Emergency Department Outpatient treatment of CELLulitis (PEDOCELL) trial: update to the study protocol and detailed statistical analysis plan (SAP).
Boland F; Quirke M; Gannon B; Plunkett S; Hayden J; McCourt J; O'Sullivan R; Eustace J; Deasy C; Wakai A
Trials; 2017 Aug; 18(1):391. PubMed ID: 28836993
[TBL] [Abstract][Full Text] [Related]
18. Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis.
Ibrahim LF; Huang L; Hopper SM; Dalziel K; Babl FE; Bryant PA
Lancet Infect Dis; 2019 Oct; 19(10):1101-1108. PubMed ID: 31420292
[TBL] [Abstract][Full Text] [Related]
19. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis.
Quirke M; Curran EM; O'Kelly P; Moran R; Daly E; Aylward S; McElvaney G; Wakai A
Postgrad Med J; 2018 Jan; 94(1107):25-31. PubMed ID: 28874503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
